CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 2 of 15

Annals of the Rheumatic Diseases

Briefs 41–80 of 596 CurrentRheuma has covered from this journal, newest publication first

Latest from Annals of the Rheumatic Diseases

All coverage, newest first

  1. Ann Rheum Dis

    Safety, biodistribution, and exploratory clinical outcomes of a novel intra-articular IL-1Ra gene therapy (PCRX-201) in moderate-to-severe knee osteoarthritis: 2-year results of a phase 1 study

    Research articleOsteoarthritis

  2. Ann Rheum Dis

    A global OMERACT ultrasound joint damage scoring system (GLODS) in rheumatoid arthritis

    Cross-sectional studyRA

  3. Ann Rheum Dis

    Circulating biomarkers in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial

    Secondary analysisSystemic sclerosis

  4. Ann Rheum Dis

    Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years

    Secondary analysisVasculitis & PMR

  5. Ann Rheum Dis

    2026 EULAR updated standardised operating procedures and methods for the development of recommendations or points to consider for the diagnosis and management of people with rheumatic and musculoskeletal diseases

    Guideline or statementAcross diseases

  6. Ann Rheum Dis

    Rheumatoid arthritis susceptibility genes show pathotype-specific expression in synovial tissue of patients with early treatment-naïve RA

    Mechanistic studyRA

  7. Ann Rheum Dis

    High-throughput plasma proteomics reveals circulating biomarkers of interstitial lung disease and progressive pulmonary fibrosis in systemic sclerosis

    Diagnostic or prognostic studySystemic sclerosis

  8. Ann Rheum Dis

    CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy

    Mechanistic studyLupus & APS

  9. Ann Rheum Dis

    Spatial transcriptomics reveals mechanism of autoimmunity driven by internalised autoantibodies

    Mechanistic studyMyositis

  10. Ann Rheum Dis

    A phase 2 trial of rilzabrutinib in IgG4-related disease

    Research articleAutoinflammatory & rare

  11. Ann Rheum Dis

    2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis

    Guideline or statementVasculitis & PMR

  12. Ann Rheum Dis

    Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort

    Cohort studyRA

  13. Ann Rheum Dis

    Single-cell analysis identifies monocyte signatures of disease activity and clinical subtypes in Behçet’s disease

    Mechanistic studyVasculitis & PMR

  14. Ann Rheum Dis

    Zanubrutinib monotherapy for IgG4-related head and neck disease

    Research articleAutoinflammatory & rare

  15. Ann Rheum Dis

    Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries

    Cohort studySpondyloarthritis & PsA

  16. Ann Rheum Dis

    Development and validation of quality indicators for lupus nephritis, based on the 2025 EULAR recommendations: adherence trends and impact on clinical outcomes

    Diagnostic or prognostic studyLupus & APS

  17. Ann Rheum Dis

    Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs

    Meta-analysisAcross diseases

  18. Ann Rheum Dis

    Functional insights into autoantibodies targeting muscarinic acetylcholine receptors in Sjögren’s disease

    Cross-sectional studySjögren's & overlap

  19. Ann Rheum Dis

    Enhancing diagnostic accuracy in axial spondyloarthritis through centralised clinical and imaging evaluation: results from a prospective multicentre project

    Diagnostic or prognostic studySpondyloarthritis & PsA

  20. Ann Rheum Dis

    Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis

    Case-control studySystemic sclerosis

  21. Ann Rheum Dis

    A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trial

    Randomized controlled trialRA

  22. Ann Rheum Dis

    Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project

    Guideline or statementSpondyloarthritis & PsA

  23. Ann Rheum Dis

    A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus

    Diagnostic or prognostic studyLupus & APS

  24. Ann Rheum Dis

    Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups

    Research articleVasculitis & PMR

  25. Ann Rheum Dis

    Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project

    Cross-sectional studyAcross diseases

  26. Ann Rheum Dis

    Comparison of the established ASAS definition and preliminary proposed data-driven cut-offs for inflammatory and structural MRI lesions in the sacroiliac joints for eligibility of patients with nonradiographic axial spondyloarthritis in clinical trials

    Secondary analysisSpondyloarthritis & PsA

  27. Ann Rheum Dis

    Uncovering the heterogeneity of care trajectories leading up to a rheumatoid arthritis diagnosis: a Swedish 10-year study

    Cohort studyRA

  28. Ann Rheum Dis

    Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care

    Cohort studyAcross diseases

  29. Ann Rheum Dis

    Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series

    Cohort studySystemic sclerosis

  30. Ann Rheum Dis

    Predictors of unacceptable pain and the impact of sociodemographic factors and comorbidities—results from a large, nationwide cohort of early rheumatoid arthritis

    Cohort studyRA

  31. Ann Rheum Dis

    Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series

    Cohort studySystemic sclerosis

  32. Ann Rheum Dis

    Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease

    Mechanistic studyAutoinflammatory & rare

  33. Ann Rheum Dis

    Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapy

    Mechanistic studyRA

  34. Ann Rheum Dis

    Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)

    Guideline or statementGout & crystals

  35. Ann Rheum Dis

    Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis

    Meta-analysisSpondyloarthritis & PsA

  36. Ann Rheum Dis

    Pulmonary arterial hypertension susceptibility and mortality among patients with systemic sclerosis with the DNASE1L3 rs35677470 (Arg206Cys) variant

    Meta-analysisSystemic sclerosis

  37. Ann Rheum Dis

    Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjögren’s disease

    Mechanistic studySjögren's & overlap

  38. Ann Rheum Dis

    Integrated transcriptomic and epigenomic profiling reveals conserved molecular subtypes across systemic autoimmune diseases

    Cross-sectional studyAcross diseases

  39. Ann Rheum Dis

    Novel HLA class I and II insights into the pathogenesis of systemic sclerosis–associated interstitial lung disease

    Meta-analysisSystemic sclerosis

  40. Ann Rheum Dis

    Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals

    Mechanistic studyRA

All 596 Briefs in ExploreShowing Briefs 41–80 of 596, newest first